Overprescribing Investigation in Alabama: First Steps for Doctors and Clinics
Updated: Oct 28
An overprescribing investigation rarely stays in one lane. The same patient charts may interest federal prosecutors, the Drug Enforcement Administration, a health-care program, a private insurer, the Alabama Board of Medical Examiners, or the Medical Licensure Commission. Each forum applies a different standard and may be working on a different timetable.
The first objective is therefore not to write a broad defense letter. It is to preserve the record, identify every authority involved, and prevent an early response in one forum from creating a problem in another.
This guide is for a doctor, prescriber, clinic owner, or administrator who has received an inquiry, subpoena, search warrant, interview request, audit notice, or licensing complaint. The companion article on how pill mill prosecutions are built explains the government's evidence model. This article focuses on the response.
The first 72 hours: preserve, identify, and slow down
Start with actions that protect accuracy:
Preserve the notice, warrant, subpoena, complaint, and service information.
Identify the agency, court, board, payer, or investigator and every stated deadline.
Stop routine destruction of potentially relevant charts, messages, billing records, schedules, policies, and audit logs.
Preserve native electronic records and access logs; do not convert everything into screenshots or PDFs and discard the originals.
Direct employees not to alter charts, add backdated explanations, coordinate recollections, or contact patients about the investigation.
Notify appropriate counsel and any required insurer without giving an unreviewed substantive account.
An incomplete chart can present a defense problem. A chart changed after notice can present a different and more serious one. Current Alabama Medical Licensure Commission Rule 545-X-4-.06 identifies knowingly falsifying, altering, or destroying records relevant to an investigation as potential unprofessional conduct. Preserve first; explain through a controlled, truthful process later.
Build a map of every parallel proceeding
Create a simple table listing the authority, document, deadline, subject, records requested, and possible consequence. A federal criminal investigation applies a proof-beyond-a-reasonable-doubt standard. An Alabama licensing proceeding may apply an administrative standard. A DEA registration issue, insurer audit, employment review, and credentialing inquiry each bring separate authority and remedies.
Do not assume that resolving one closes the others. A response to a licensing complaint may become evidence elsewhere. A billing explanation may be read as a prescribing admission. A clinic policy prepared after the fact may conflict with the policy that actually governed the period under review.
Counsel should also identify who represents the entity and who represents individual clinicians or employees. Their interests may overlap without being identical.
Preserve the medical record as it actually existed
The core record may include more than progress notes:
initial history and physical examination;
diagnoses and treatment objectives;
informed-consent and controlled-substance agreements;
drug screens, pill counts, and referrals;
Alabama Prescription Drug Monitoring Program checks;
refill communications and early-fill requests;
pharmacy contacts and prior-authorizations;
risk discussions, naloxone decisions, and taper plans;
billing records and coding history; and
electronic audit trails showing when entries were made or changed.
The Alabama Board of Medical Examiners' current prescribing guidance collects the state's requirements and links governing rules. Rule 540-X-4-.06 addresses prescription form and issuance requirements. Rule 540-X-4-.09 addresses risk and abuse mitigation, including specified dosage thresholds, Prescription Drug Monitoring Program checks, documentation, and exceptions.
The Alabama PDMP is confidential and subject to controlled access. A prescriber should not conduct a new, informal investigation through another person's credentials or beyond authorized use. Preserve the lawful records already available and obtain advice about any further review.
Separate documentation questions from criminal intent
A documentation deficiency, an administrative violation, and a federal drug-distribution offense are not interchangeable.
Under 21 U.S.C. § 841, federal law prohibits knowing or intentional distribution or dispensing of a controlled substance except as authorized. 21 C.F.R. § 1306.04 states that a controlled-substance prescription must be issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice.
In Ruan v. United States, the United States Supreme Court held that once a defendant produces evidence that the conduct was authorized, the government must prove beyond a reasonable doubt that the defendant knowingly or intentionally acted in an unauthorized manner.
That is a subjective knowledge or intent requirement. It does not make objective medical evidence irrelevant. Charting, examination, dose, combinations, warnings, monitoring, referrals, and patient conduct may all be circumstantial evidence from which intent is argued. The response should therefore examine both what happened clinically and what the practitioner understood at the time.
Conduct a disciplined chart-by-chart review
Aggregate statistics can identify outliers, but they do not explain individual treatment. A defensible review should use a consistent chronology and criteria across a representative or charged set of charts.
For each patient, consider the diagnosis, prior treatment, examination, objective findings, risk factors, monitoring, dosage changes, aberrant behavior, referrals, informed discussions, and reasons for continuing or changing therapy. Compare the contemporaneous record with the standards and policies in effect at that time—not a policy written after the inquiry began.
Independent medical review may be appropriate, but the reviewer needs a defined question and a complete record. A conclusory letter that “the care was appropriate” is less useful than a transparent analysis that identifies strengths, weaknesses, missing information, and alternative explanations.
Keep prescribing and billing theories separate
Federal investigations sometimes include both controlled-substance and health-care-fraud theories. 18 U.S.C. § 1347 addresses knowingly and willfully executing a scheme to defraud a health-care benefit program or obtain its money or property through false representations.
A disputed code, copied note, or documentation gap does not automatically prove unlawful prescribing. Nor does evidence about prescribing automatically prove a fraudulent billing scheme. Analyze the elements, records, decisionmakers, and time periods separately, even when investigators place them in the same subpoena.
Protect privacy through the response process
Patient charts contain protected information. A subpoena, warrant, board rule, patient authorization, or other law may permit or require disclosure, but the scope and method still matter. Do not email a chart collection to personal accounts, upload it to an unapproved service, or circulate it through the clinic merely because an investigation exists.
Counsel can help structure collection, privilege, expert review, and production while respecting legal obligations. Privilege is not created by copying a lawyer on an ordinary business discussion, and clinic counsel does not automatically represent every employee.
Frequently asked questions
Should I agree to an immediate interview?
Not before understanding who is asking, your status, the subject, and the other proceedings. A request for an interview is different from a lawful command, but neither should be handled by guessing.
Can I add a late note to explain the care?
Do not alter or backdate the original record. Health systems may have legitimate late-entry procedures, but using one after notice of an investigation requires careful, transparent advice. Preserve the audit trail.
Does a high dose or large patient panel prove a federal crime?
No single metric proves every element. It may prompt scrutiny and may be used with charts, testimony, communications, billing, and expert evidence. The legal question remains tied to the governing offense and proof of knowledge or intent.
Coordinate the response before answering on the merits
Elliott Owen Lipinsky handles Alabama criminal-defense matters, including controlled-substance investigations. If a notice, subpoena, interview request, or search has reached a practice, you may request an initial case review. Do not send patient charts, protected health information, controlled-substance records, confidential business files, or time-critical details through the website form.
Reviewed October 6, 2026. Controlled-substance, billing, privacy, and licensing law can change, and the governing rules depend on the prescriber and forum. This article provides general information, not legal advice. Reading it or contacting the firm does not create an attorney-client relationship. Representation begins only after the firm accepts the matter in writing.
